Teladoc Health, Inc. TDOC
We take great care to ensure that the data presented and summarized in this overview for Teladoc Health, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding TDOC
View all-
Black Rock Inc. New York, NY21.6MShares$194 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.4MShares$157 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct8.37MShares$75.3 Million0.21% of portfolio
-
Goldman Sachs Group Inc New York, NY5.95MShares$53.5 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.91MShares$44.2 Million0.07% of portfolio
-
State Street Corp Boston, MA4.63MShares$41.7 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY4.13MShares$37.1 Million1.06% of portfolio
-
Geode Capital Management, LLC Boston, MA3.93MShares$35.3 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.52MShares$31.7 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.2MShares$28.8 Million0.01% of portfolio
Latest Institutional Activity in TDOC
Top Purchases
Top Sells
About TDOC
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
Insider Transactions at TDOC
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 02
2024
|
Kelly Bliss President, U.S. Group Health |
SELL
Open market or private sale
|
Direct |
897
-3.08%
|
$7,176
$8.68 P/Share
|
|
Oct 01
2024
|
Kelly Bliss President, U.S. Group Health |
BUY
Exercise of conversion of derivative security
|
Direct |
2,631
+8.29%
|
-
|
|
Sep 20
2024
|
Jason Eric Evans Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,065
+50.0%
|
-
|
|
Sep 12
2024
|
Thomas Mckinley Director |
BUY
Open market or private purchase
|
Direct |
4,000
+9.29%
|
$28,000
$7.69 P/Share
|
|
Sep 04
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
468
-1.37%
|
$3,276
$7.26 P/Share
|
|
Sep 04
2024
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
20,773
-50.0%
|
$145,411
$7.26 P/Share
|
|
Sep 03
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,114
-3.16%
|
$7,798
$7.16 P/Share
|
|
Sep 03
2024
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
1,617
-3.75%
|
$11,319
$7.16 P/Share
|
|
Sep 03
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
4,218
-5.11%
|
$29,526
$7.16 P/Share
|
|
Sep 03
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
1,777
-5.35%
|
$12,439
$7.16 P/Share
|
|
Sep 03
2024
|
James L. Cave INTERIM CAO |
SELL
Open market or private sale
|
Direct |
555
-3.86%
|
$3,885
$7.16 P/Share
|
|
Sep 03
2024
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
2,083
-4.09%
|
$14,581
$7.16 P/Share
|
|
Sep 03
2024
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
2,817
-5.74%
|
$19,719
$7.16 P/Share
|
|
Sep 03
2024
|
Nikolaos P. Nanis Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
1,033
-1.35%
|
$7,231
$7.16 P/Share
|
|
Sep 03
2024
|
Mala Murthy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,750
-9.26%
|
$61,250
$7.16 P/Share
|
|
Sep 03
2024
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
1,795
-3.84%
|
$12,565
$7.16 P/Share
|
|
Aug 30
2024
|
Vidya Raman Tangella CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,117
+4.27%
|
-
|
|
Aug 30
2024
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
BUY
Exercise of conversion of derivative security
|
Direct |
5,504
+4.2%
|
-
|
|
Aug 30
2024
|
Michael Willem Waters CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,313
+4.84%
|
-
|
|
Aug 30
2024
|
Daniel Trencher CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,920
+4.87%
|
-
|
Last 12 Months Summary
| Open market or private purchase | 19K shares |
|---|---|
| Exercise of conversion of derivative security | 718K shares |
| Open market or private sale | 410K shares |
|---|